Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.
about
Application of human factors engineering (HFE) to the design of a naloxone auto-injector for the treatment of opioid emergencies.Misuse of Novel Synthetic Opioids: A Deadly New Trend.Comparative Usability Study of a Novel Auto-Injector and an Intranasal System for Naloxone Delivery.Naloxone therapy in opioid overdose patients: intranasal or intravenous? A randomized clinical trialFlumazenil, naloxone and the 'coma cocktail'.Review of naloxone safety for opioid overdose: practical considerations for new technology and expanded public access.Naloxone for opioid overdose prevention: pharmacists' role in community-based practice settings.A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice traineesIntravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose.Prehospital medication administration: a randomised study comparing intranasal and intravenous routesUse of Naloxone by Emergency Medical Services during Opioid Drug Overdose Resuscitation Efforts.Assessment of the safety and ease of use of the naloxone auto-injector for the reversal of opioid overdose.EMS runs for suspected opioid overdose: implications for surveillance and prevention.Intranasal treatment of central nervous system dysfunction in humans.Prescribe to Prevent: Overdose Prevention and Naloxone Rescue Kits for Prescribers and Pharmacists.Emergency medical services naloxone access: a national systematic legal review.International patent applications for non-injectable naloxone for opioid overdose reversal: Exploratory search and retrieve analysis of the PatentScope database.Overdose Education and Naloxone Distribution Program Attendees: Who Attends, What Do They Know, and How Do They Feel?Multiple Naloxone Administrations Among Emergency Medical Service Providers is Increasing.Pharmacokinetics after a single dose of naloxone administered as a nasal spray in healthy volunteers.Opiate addiction and overdose: experiences, attitudes, and appetite for community naloxone provision.Use of Intranasal Naloxone by Basic Life Support Providers.Working together: Expanding the availability of naloxone for peer administration to prevent opioid overdose deaths in the Australian Capital Territory and beyond.The feasibility of pharmacy-based naloxone distribution interventions: a qualitative study with injection drug users and pharmacy staff in Rhode Island.Take-home naloxone treatment for opioid emergencies: a comparison of routes of administration and associated delivery systems.Incorporation of poison center services in a state-wide overdose education and naloxone distribution program.Police Officers Can Safely and Effectively Administer Intranasal Naloxone.Opioid overdose prevention through pharmacy-based naloxone prescription program: Innovations in health care delivery.Basic and Advanced EMS Providers Are Equally Effective in Naloxone Administration for Opioid Overdose in Northern New England.Intranasal naloxone and related strategies for opioid overdose intervention by nonmedical personnel: a review.Intranasal Opioid Administration in Rhesus Monkeys: PET Imaging and Antinociception.Intranasal naloxone soon to become part of evolving clinical practice around opioid overdose prevention.Pharmacokinetic Properties and Human Use Characteristics of an FDA-Approved Intranasal Naloxone Product for the Treatment of Opioid Overdose.Public Perspectives on Expanding Naloxone Access to Reverse Opioid Overdoses.Law enforcement attitudes towards naloxone following opioid overdose training.Clinical provision of improvised nasal naloxone without experimental testing and without regulatory approval: imaginative shortcut or dangerous bypass of essential safety procedures?Intravenous use of intranasal naloxone: A case of overdose reversal.Measuring a Crisis: Questioning the Use of Naloxone Administrations as a Marker for Opioid Overdoses in a Large U.S. EMS System.Analysis of the Efficiency of Microencapsulated Sustained-Release Form of Naloxone on the Experimental Model of Fentanyl Poisoning.
P2860
Q28468357-BDE74228-3AFC-4F47-A02E-0C08D392CB8DQ30491920-6573D362-A319-46F1-9BCA-6EFDAB75F8D4Q30654725-B6D66B26-BABD-42E8-A1A9-CC86B42159FDQ33701297-C3133AC2-0FA4-4763-BD8D-105626A3C3BDQ34498099-4186A410-1BEF-4A74-9BE2-627ABF17531EQ35019475-8CE350EA-4B6B-464D-A74C-FB4A8B710C6CQ35183142-D6CF6731-0B48-4634-B7B8-9214212819C6Q35751870-EBE425BC-0766-42C2-B354-F907A22C0231Q35847707-C2CCC14A-68DA-480F-9A7A-DE5EC74C6CA8Q35932315-BCECA91E-C646-4FF8-90B7-BA4188A388DDQ36200006-7C4182AE-E54B-49F4-AE13-8C423C87E6C8Q36703521-EBF6CD18-8AF0-4A58-A423-FDA4720F193EQ36726275-779DD2EE-E3E8-443E-89F1-5FAA8977E952Q36929678-43B068A6-6811-4C61-AFF8-21A5378784A0Q37142166-63D7E75F-3912-47BC-86C7-C264ABE3584BQ37309608-35C612AC-B201-4A04-B1DC-2912AA5C475FQ38259433-7B48575D-05FF-4D90-825E-EDE37BAC9446Q38734821-DF49651A-40E1-45E6-B10A-30F75EDFA6F1Q38751059-49F08D75-5E17-4CAA-BF06-75178275C859Q38798345-4B9454DD-6689-486A-A75D-98C224CB6540Q38818902-904CAF24-3191-41AF-897D-7FF1400D0114Q38936820-7F515EC1-65F6-44DE-9AE4-9A535C732A34Q38976288-74EC4E28-0903-430A-BB64-4727AAA03ECDQ39120500-112532FC-D731-4C54-9B3A-71FDD460D522Q39405017-2EE05F77-B97D-4438-B768-50FF0ACB63CCQ39411044-3BBB6600-E027-41DC-A5A1-8F9F0ED1FB80Q39740001-F50F5279-717C-4176-B06B-D1150E0A06CAQ39740713-EB5E2255-0CAF-4286-848F-306A228641A0Q39778821-FD51FC6B-EEC5-4DD2-9EAA-874F1AC33038Q41986644-769AC42A-416F-4EC0-803E-F1278D1AC10EQ42687927-48DCCEB1-F9D4-4021-9738-331B94062DADQ42713276-4DB1DDC6-5045-4EAE-BEEB-23BFEFD76990Q44335948-C9DB3163-E7C4-489B-87CD-43AD508F3A44Q44336921-39BA9B71-93EC-46BF-8510-6DBC5F54EA40Q44339635-77A21D98-AA3B-44F5-9828-973094377BFFQ44340591-6E8ADC70-E0F5-4E04-95E5-CB4CDB7EFDF1Q45753417-13D52FCF-55DB-44FF-8F81-9CEBD6D9EEB1Q46695159-0CD27061-AF59-4ECC-8870-7D38B418D6D2Q47214991-6174BFE8-A9D7-4171-AA20-D73D089CAD3FQ47734701-5E1D8E8F-C36A-476A-B6D1-75871C338307
P2860
Randomized controlled trial comparing the effectiveness and safety of intranasal and intramuscular naloxone for the treatment of suspected heroin overdose.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh
2009年學術文章
@zh-hant
name
Randomized controlled trial co ...... of suspected heroin overdose.
@en
Randomized controlled trial co ...... of suspected heroin overdose.
@nl
type
label
Randomized controlled trial co ...... of suspected heroin overdose.
@en
Randomized controlled trial co ...... of suspected heroin overdose.
@nl
prefLabel
Randomized controlled trial co ...... of suspected heroin overdose.
@en
Randomized controlled trial co ...... of suspected heroin overdose.
@nl
P2093
P1433
P1476
Randomized controlled trial co ...... t of suspected heroin overdose
@en
P2093
Bill Barger
Damien Jolley
Paul Dietze
P2860
P304
P356
10.1111/J.1360-0443.2009.02724.X
P407
P577
2009-12-01T00:00:00Z